| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06993610 | Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | RECRUITING | PHASE2 | 2025-05-16 | 2027-03 | 2026-09 |
| NCT06843239 | Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) | RECRUITING | PHASE2 | 2025-02-06 | 2027-05 | 2026-12 |